Ad
related to: Skyrizihealth.clevelandclinic.org has been visited by 100K+ users in the past month
Search results
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 hours agoTotal net revenues were $12.3 billion approximately $400 million ahead of our expectations. This overachievement was driven by our ex-Humira growth...
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 10 hours agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
Analyst Report: AbbVie Inc.
Morningstar Research via Yahoo Finance· 5 hours agoAbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off ...
‘AI Craze’ Powers Best Week in 2024 for Stocks: Markets Wrap
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- A rally in the world’s largest technology companies lifted stocks, with Wall Street...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 7 hours agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
Drugmaker AbbVie expects Humira volume erosion to worsen By Reuters
Investing.com· 10 hours agoIts shares were down 2% in morning trade on Friday, after the company forecast U.S. Humira sales...
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 7 hours agoWhile the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed...
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
Market Watch· 10 hours agoAbbVie Inc. on Friday reported first-quarter results that beat expectations, even as sales of...
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 8 hours agoAbbVie raised its full-year earnings outlook despite continuing sales declines for autoimmune drug...
CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 8 hours agoResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss...
